In March 2025, the company announced new programs for any immediate-to-client giving of its Wegovy weight loss drug. The company recognized a fresh pharmacy, known as NovoCare, which would demand clients $499 every month for access to the drug, under 50 percent the cost of the drug as a result of other pharmaceutical distribution networks.[53]Notew